CO2 Detector for Neonatal Resuscitation
(CO2-Vent Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Pedi-Cap CO2 Detector for neonatal resuscitation?
Is the CO2 detector safe for use in newborns?
How does the CO2 detector treatment for neonatal resuscitation differ from other treatments?
The CO2 detector treatment for neonatal resuscitation is unique because it uses a colorimetric carbon dioxide detector to confirm proper airway placement and effective ventilation by changing color when exposed to exhaled CO2. This provides immediate visual feedback, which is not available with traditional methods, helping ensure that newborns receive adequate ventilation during resuscitation.12367
What is the purpose of this trial?
The goal of this study is to determine if using a Pedi-Cap (a type of colorimetric carbon dioxide detector) during face mask ventilation (PPV) for newborn infants in the delivery room will lower the time of PPV needed. A group of nurses, doctors, and respiratory therapists, called the neonatal resuscitation team, will either use or not use the Pedi-Cap during face mask PPV for infants born at ≥30 weeks' gestation.A randomization generator will assign each month to either use the Pedi-Cap or not use the Pedi-Cap. The researchers will collect information from the medical chart to find the infant and mother's information, medical interventions done in the delivery room, and lab values. In addition, resuscitation team members will fill out a survey of their experiences of using or not using the Pedi-Cap during delivery room facemask PPV.
Research Team
Riti Chokshi
Principal Investigator
University of Texas
Eligibility Criteria
This trial is for newborn infants born at or after 30 weeks' gestation who need non-invasive positive pressure ventilation (PPV) in the delivery room. The neonatal resuscitation team must be present before delivery to participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Neonatal resuscitation team uses or does not use the Pedi-Cap during face mask PPV for infants born at ≥30 weeks' gestation in the delivery room
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of mechanical ventilation duration and need for NICU admission
Survey
Resuscitation team members complete a survey to assess their experience with each study arm
Treatment Details
Interventions
- Pedi-Cap
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor